netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Chapter Links...
 Details...
02.06.03  Expand sub section  Other anitanginal drugs
Nicorandil
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Link  MHRA drug safety update Nov 2015 risk of serious skin, mucosal, and eye ulceration, gastrointestinal ulcers which may progress to perforation, haemorrhage, fistula, or absces
   
Ivabradine (Procoralan®)
View adult BNF View SPC online View childrens BNF
Formulary

Amber Traffic Light 

  • Usually specialist prescribing only for arrhythmia but may be appropriate for shared care where an individual patient specific protocol is agreed (APCO January 2008).
  • For patients with chronic heart failure in line with local Amber Continuation Guideline (APCO September 2018). 

Amber Traffic Light As add on therapy for symptomatic treatment of patients with stable angina in line with Shared Care Protocol.


APCO March 2013.

 

 
Link  MHRA: Cardiac side effects of ivabradine - risk minimisation advice
Link  MHRA: Carefully monitor for bradycardia
Link  NICE CG126: Guidance on Stable Angina (2011)
   
Ranolazine (Ranexa®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Shared Care Protocol

As add on therapy for symptomatic treatment of patients with stable angina in line with Shared Care Protocol.

APCO July 2012.

 
Link  NICE CG126: Guidance on Stable Angina (2011)
   
Perhexiline Maleate 100mg Tablets
View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed
Red

For the treatment of hypertrophic cardiomyopathy and heart failure in patients who still have symptoms despite maximal dose with standard therapy.

APCO November 2013.

 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary